These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36998084)

  • 21. Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate?
    Obaid O; Anand T; Nelson A; Reina R; Ditillo M; Stewart C; Douglas M; Friese R; Gries L; Joseph B
    J Trauma Acute Care Surg; 2022 Oct; 93(4):453-460. PubMed ID: 35838235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.
    Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A
    Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial.
    Bartoszko J; Martinez-Perez S; Callum J; Karkouti K;
    Br J Anaesth; 2022 Sep; 129(3):294-307. PubMed ID: 35773027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.
    Rahe-Meyer N; Solomon C; Hanke A; Schmidt DS; Knoerzer D; Hochleitner G; Sørensen B; Hagl C; Pichlmaier M
    Anesthesiology; 2013 Jan; 118(1):40-50. PubMed ID: 23249928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial).
    da Luz LT; Callum J; Beckett A; Hucke HP; Carroll J; Grewal D; Schwartz B; Peng H; Engels PT; Parry N; Petrosoniak A; Tien H; Nathens AB; Scales D; Karkouti K
    BMJ Open; 2021 Sep; 11(9):e051003. PubMed ID: 34479938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aetiology and treatment of severe postpartum haemorrhage.
    Edwards HM
    Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.
    Schöchl H; Nienaber U; Maegele M; Hochleitner G; Primavesi F; Steitz B; Arndt C; Hanke A; Voelckel W; Solomon C
    Crit Care; 2011; 15(2):R83. PubMed ID: 21375741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury.
    Mesar T; Larentzakis A; Dzik W; Chang Y; Velmahos G; Yeh DD
    JAMA Surg; 2017 Jun; 152(6):574-580. PubMed ID: 28273299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review.
    Aubron C; Reade MC; Fraser JF; Cooper DJ
    J Crit Care; 2014 Jun; 29(3):471.e11-7. PubMed ID: 24508201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Obstetric Hemorrhage with Fibrinogen Concentrate.
    Sahin AS; Ozkan S
    Med Sci Monit; 2019 Mar; 25():1814-1821. PubMed ID: 30852583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial.
    Nascimento B; Callum J; Tien H; Peng H; Rizoli S; Karanicolas P; Alam A; Xiong W; Selby R; Garzon AM; Colavecchia C; Howald R; Nathens A; Beckett A
    Br J Anaesth; 2016 Dec; 117(6):775-782. PubMed ID: 27956676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients.
    Ayaganov D; Kuanyshbek A; Vakhrushev I; Li T
    J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):80-85. PubMed ID: 38016817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic effect of fibrinogen concentrate on traumatic massive hemorrhage: a propensity score matching study.
    Heo Y; Chang SW; Lee SW; Ma DS; Kim DH
    Trauma Surg Acute Care Open; 2024; 9(1):e001271. PubMed ID: 38298819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial.
    Wikkelsø AJ; Edwards HM; Afshari A; Stensballe J; Langhoff-Roos J; Albrechtsen C; Ekelund K; Hanke G; Secher EL; Sharif HF; Pedersen LM; Troelstrup A; Lauenborg J; Mitchell AU; Fuhrmann L; Svare J; Madsen MG; Bødker B; Møller AM;
    Br J Anaesth; 2015 Apr; 114(4):623-33. PubMed ID: 25586727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective register study comparing fibrinogen treated trauma patients with an injury severity score matched control group.
    Almskog LM; Hammar U; Wikman A; Östlund A; Svensson J; Wanecek M; Ågren A
    Scand J Trauma Resusc Emerg Med; 2020 Jan; 28(1):5. PubMed ID: 31964405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.
    Winearls J; Wullschleger M; Wake E; Hurn C; Furyk J; Ryan G; Trout M; Walsham J; Holley A; Cohen J; Shuttleworth M; Dyer W; Keijzers G; Fraser JF; Presneill J; Campbell D
    Trials; 2017 May; 18(1):241. PubMed ID: 28549445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.
    Okerberg CK; Williams LA; Kilgore ML; Kim CH; Marques MB; Schwartz J; Pham HP
    Vox Sang; 2016 Oct; 111(3):292-298. PubMed ID: 27248502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.